BACI-RX Drug Patent Profile
✉ Email this page to a colleague
When do Baci-rx patents expire, and what generic alternatives are available?
Baci-rx is a drug marketed by X Gen Pharms and is included in one NDA.
The generic ingredient in BACI-RX is bacitracin. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Baci-rx
A generic version of BACI-RX was approved as bacitracin by PADAGIS US on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACI-RX?
- What are the global sales for BACI-RX?
- What is Average Wholesale Price for BACI-RX?
Summary for BACI-RX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 20 |
| Patent Applications: | 2,723 |
| DailyMed Link: | BACI-RX at DailyMed |
US Patents and Regulatory Information for BACI-RX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X Gen Pharms | BACI-RX | bacitracin | POWDER;FOR RX COMPOUNDING | 061580-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
